Skip to main content

Table 3 Adverse Events, at Least Possibly Related to Treatment with Avelumab

From: Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma

Adverse Event Grade 1 Grade 2 Grade 3 Grade 4
Tumor pain 1 (13%)    
Back pain   1 (13%)   
Extremity pain 1 (13%)    
Fever 1 (13%)    
Flu-like symptoms 1 (13%)    
Chills 1 (13%)    
Fatigue 3 (38%) 1 (13%)   
Nausea 1 (13%)    
Wheezing 1 (13%)    
Bronchial infection   1 (13%)   
Ear and labyrinth disorder (fullness)   1 (13%)   
Urinary urgency   1 (13%)   
Autoimmune disorder    3 (38%) 2 (25%)
Hypokalemia     1 (13%)
Hypomagnesemia   1 (13%)